bufalin and osimertinib

bufalin has been researched along with osimertinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, F; Gong, YB; Kang, XH; Liao, MJ; Lu, ZH; Miao, ZH; Wang, Y; Xu, ZY; Zhao, KL	1

Other Studies

1 other study(ies) available for bufalin and osimertinib

Article	Year
Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer. Toxicology and applied pharmacology, 2019, 09-15, Volume: 379 Topics: Acrylamides; Aniline Compounds; Animals; Antineoplastic Agents; Bufanolides; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Fluorescent Antibody Technique; Genes, erbB-1; In Situ Nick-End Labeling; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Transplantation	2019

Article

Year

Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer.

Toxicology and applied pharmacology, 2019, 09-15, Volume: 379

Topics: Acrylamides; Aniline Compounds; Animals; Antineoplastic Agents; Bufanolides; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Fluorescent Antibody Technique; Genes, erbB-1; In Situ Nick-End Labeling; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Transplantation

2019